Clinomic

Clinomic raises €23M in Series B funding to accelerate international expansion and enhance critical care

14th April, 2025

Chris Davis

Writer

Clinomic raises €23M in Series B funding to accelerate international expansion and enhance critical care

What does Clinomic do?

Clinomic is a medical technology company that developed Mona, an integrated platform designed to streamline intensive care workflows by recording, organizing, analyzing, and visualizing patient and operational data. This platform provides healthcare professionals with real-time insights to enhance decision-making in critical care.

How much did they raise?

The company raised €23M in a Series B round, led by DeepTech & Climate Fonds and a private family office, marking a significant milestone for Clinomic as it continues to innovate and expand its offerings in the medical technology sector.

What are their plans for the money?

With the newly raised funds, Clinomic intends to accelerate its expansion into international markets, enhance its AI and data capabilities, and deepen its impact on critical care. This investment is expected to drive further innovation in healthcare technology, ultimately improving patient outcomes and operational efficiencies.

What have they achieved so far?

Clinomic has already demonstrated significant progress with its Mona platform, developed by care physicians from RWTH Aachen University Hospital, which successfully streamlines intensive care workflows and provides critical real-time insights to healthcare professionals.

Key Contacts

Georg Griesemann
CEO
Arne Peine
Chief Technology Officer & Co-Founder

Company Links

Looking for startup leads?

Every week we source, enrich and send you leads of decision makers from recently funded startups. Sent to you every Monday.

Learn more

Newsletter

Get a daily roundup of recently funded startups.

Recently raised

The latest funding rounds from our newsroom